Jazz Pharmaceuticals-GW Pharmaceuticals deal needs regulatory approval in the UK
MLex Summary: Jazz Pharmaceuticals' acquisition of GW Pharmaceuticals needs regulatory approval in the United Kingdom, GW Pharmaceuticals Chief Financial Officer Renée D. Galá said on a conference call Feb. 3. The transcript...To view the full article, register now.
Already a subscriber? Click here to view full article